Short answer
Cognizant (CTSH) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $5.7B (up 4.6% year over year) with net income of $627M.
Q3 2026 key financials · XBRL
- Revenue
- $5.7B
- +4.6% YoY · +3.3% QoQ
- Net income
- $627M
- +128.8% YoY · −1.4% QoQ
- Operating margin
- 15.4%
- EPS (diluted)
- $1.39
- +143.9% YoY · +2.2% QoQ
Source: XBRL data from the Cognizant (CTSH) Q3 2026 10-Q on SEC EDGAR. USD.
Cognizant Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $5,664M, up $249M or 4.6% YoY, 4.8% constant currency
- GAAP operating margin 15.4% vs 16.0%; adjusted margin 16.3% vs 16.0%
- Best segment Financial Services, revenue up 12.0%; worst Health Sciences, revenue down 1.1%
- Operating cash flow $1,836M YTD vs $2,025M; cash and short-term investments $1,552M
- Project Leap costs revised to $180M-$250M; AI investment, tariffs, macro uncertainty and communications-media weakness as headwinds
Risk Factors
- Project Leap disruption: Headcount reductions may cause loss of institutional knowledge and impair client-service delivery
- Project Leap costs: Expected total charges of $180 million to $250 million
- Cost-savings execution: Unforeseen delays or costs could prevent anticipated operational efficiencies
- Workforce retention: Restructuring may hinder recruitment and retention of remaining employees
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Cognizant quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.